Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... 20001-3710, USA. Keywords: City:Santa Fe, State:NM, Country:United States, AIDS, Acquired Immunodeficiency Syndrome, Addiction Medicine, Behavior, Gastroenterology, ... "We examined sexually transmitted infection (STI), HIV, and hepatitis virus prevalence and risk behaviors among truck drivers. We asked participants ... Human Immunodeficiency Virus Bacterial Infection, Infectious Disease, Public Health, Therapy, Treatment, Virology. This article was prepared by AIDS Weekly editors from ...
2009 NOV 23 ... "The stigma of HIV-infection may profoundly affect the lives of persons living with HIV/AIDS (PLHA). However few studies have examined the association of HIV stigma with multiple ... have examined the association of HIV stigma with multiple components of HIV treatment and care," scientists in the United States report. "To estimate the ... stigma and: self-reported access to care, regular source of HIV care, and antiretroviral therapy adherence; and to test whether mental health mediates these associations. ...
2009 NOV 23 ... USA. Keywords: City:Gainesville, State:FL, Country:United States, HIV/AIDS Co-Infection, AIDS, Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency ... is difficult to treat, given the propensity for drug interactions between the rifamycins and the antiretroviral drugs. We examined the pharmacokinetics of rifabutin before and after ... Protease Inhibitor, Rifabutin, Ritonavir, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology, University of Florida. This article was ...
2009 NOV 29 ... The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of ... its own replication.At DKFZ, Associate Professor (PD) Dr. Stephanie Laufs and Dr. Frank Giordano are trying to find out whether AIDS viruses can be used as gene ... developing new, specific AIDS drugs.Like all retroviruses, the AIDS virus (HIV) integrates its DNA into the genome of the infected cell. As integration sites, HIV ... trying to find out whether AIDS viruses can be used as gene delivery vehicles in gene therapy. Therefore, it is crucial for them to know where exactly HIV integrates into the genetic ...
Subject: Helmholtz Association of German Research Centres
2009 NOV 23 ... the unique child-centered methodology behind Plan's many successes in the areas of HIV/AIDS, Tsunami recovery, malaria, nutrition, and water and sanitation. Plan works ... HIV, Human Immunodeficiency Virus, Malaria, Pediatrics, Prevent Disease, Public Health, Therapy, Treatment, Virology, Plan Usa. This article was prepared by AIDS Weekly ...
2009 NOV 23 ... A proven and cost-effective strategy for turning the tide on global AIDS still remains significantly underutilized, World Vision warned in advance of World AIDS ... warned in advance of World AIDS Day. Efforts to prevent mother-to-baby transmission of HIV must be urgently scaled up in high-prevalence countries to avoid needless infection of ... which is essential in order to be able to test mothers for HIV and begin antiretroviral therapy that can cut the risk of mother-to-child transmission to virtually zero. Even before ...
2009 NOV 23 ... St., Oxford OX2 6DP, England. Keywords: City:Seville, Country:Spain, HIV/AIDS, AIDS, Acquired Immunodeficiency Syndrome, Antimicrobials, Antivirals, Chemotherapy, ... received no treatment (control group). Plasma viral load was evaluated on days 0, 2, 5 and 8. Baseline Trofile ® was performed in MCT group patients. The maraviroc clinical ... day exposure to maraviroc (MCT group); six HIV-infected patients without antiretroviral therapy received no treatment (control group). Plasma viral load was evaluated on days 0, 2, 5 ...
2009 NOV 23 ... (HIV) living longer with antiretroviral therapy (ART) are more likely to develop non-AIDS-defining cancers such as adenocarcinoma of the colon. There have been limited case ... "The aim of this study was to characterize the clinicopathologic findings and outcome in a series of HIV-infected patients diagnosed and treated for colon ...
2009 NOV 23 ... non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278/rilpivirine is an anti-AIDS therapeutic agent with high oral bioavailability despite its high hydrophobicity. ... (similar to 100-120 nm. in diameter) at low pH in surfactant-independent fashion and good oral bioavailability," investigators in the United States report. ... Enzyme Research, AIDS, Acquired Immunodeficiency Syndrome, Drug Development, Enzymes, HIV, Human Immunodeficiency Virus, Medicinal Chemistry, Nucleoside Reverse Transcriptase ... Chemistry, Nucleoside Reverse Transcriptase Inhibitor, Physiology, Proteins, Proteomics, Therapy, Treatment, Virology, Rutgers University. This article was prepared by AIDS ...
2009 NOV 23 ... Chicago, IL 60637-2954, USA. Keywords: City:Tourcoing, Country:France, HIV/AIDS, AIDS, Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, ... of subsequent treatment efficacy. The aim of this study was to assess the safety and efficacy of a regimen containing raltegravir, etravirine, and darunavir/ritonavir for ... in human immunodeficiency virus (HIV)-infected patients receiving failing antiretroviral therapy is a key determinant of subsequent treatment efficacy. The aim of this study was to ...
2009 NOV 23 ... Data detailed in 'Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART' have ... elucidate associations between CD4 cell counts achieved during virally suppressive HAART and risks of AIDS or death." "Inclusion criteria were: CD4 cell count <200 ... highly active antiretroviral therapy (HAART) are uncertain. We analysed data from HIV-infected men participating in the Multicenter AIDS Cohort Study (MACS) to elucidate ...
2009 NOV 23 ... Keywords: City:Cold Spring Harbor, State:NY, Country:United States, HIV/AIDS, AIDS, Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, ... thereby inhibiting splicing at that exon's alternative 3' splice site. tat exon 3 and the preceding intron of HIV-1 pre-mRNA can fold into an elaborate RNA secondary ... Immunology, Interferon Alfa-2b, Intron, Pharmaceuticals, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology. This article was prepared by AIDS Weekly ...
2009 NOV 23 ... of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial,' new data in HIV/AIDS. According to recent research from Liverpool, the United Kingdom, "Genotypic algorithms ... St., Malden, MA 02148, USA. Keywords: United Kingdom, Liverpool, HIV/AIDS Therapy, AIDS, Acquired Immunodeficiency Syndrome, Clinical Trial Research, Darunavir, Drugs, ...
2009 NOV 23 ... 19312, USA. Keywords: City:New Hyde Park, State:NY, Country:United States, AIDS, Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, Antivirals, ... has increased, it is more likely that this condition will be diagnosed more frequently and earlier in the course of the disease andHIV infection," scientists in the United ... virus (HIV)-infected patients after the introduction of combined antiretroviral therapy, pulmonary arterial hypertension (PAH) has become an important cause of morbidity. As ...
2009 NOV 23 ... Fresh data on HIV/AIDS co-infection are presented in the report 'Detection of Helicobacter pylori, ... are presented in the report 'Detection of Helicobacter pylori, Enterococcus faecalis, and Pseudomonas aeruginosa in the subgingival biofilm of HIV-infected subjects undergoing ... Virus Bacterial Infection, Infectious Diseases, Inflammation, Periodontitis, Polymerase, Therapy, Treatment, Virology. This article was prepared by AIDS Weekly editors from ...
2009 NOV 23 ... activity of ETV was predicted using different interpretation systems: International AIDS Society-USA (IAS-USA), Stanford, Rega and Agence Nationale de Recherches sur le Sida et ... mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS),' is the subject of a report. According to recent research ... Main St., Malden, MA 02148, USA. Keywords: Switzerland, Zurich, HIV/AIDS Therapy, AIDS, Acquired Immunodeficiency Syndrome, Antiviral, Clinical Trial Research, Drug ...
2009 NOV 23 ... concept trial of TBR-652." These data were presented at the 12th European AIDS Conference (EACS), held November 11-14, 2009 in Cologne, Germany. The poster ... Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious ... provide further basis for the continued development of TBR-652 for the treatment of HIV," said James Sapirstein, CEO. "Providing patients with well-tolerated, once-daily ... Human Immunodeficiency Virus, Infectious Diseases, Pharmaceuticals, Pharmacokinetics, Therapy, Treatment, Virology, Tobira Therapeutics Inc. This article was prepared by ...
2009 NOV 29 ... more than 8.6 million, more than the total number who die from cancer, tuberculosis, HIV/AIDSand malaria combined.However, the risk for women is largely under-estimated, ... underrepresentation is particularly noticeable in the fields of cholesterol-lowering therapy, ischaemic heart disease and heart failure.Professor Roberto Ferrari, ...
